BioNTech begins work on updated vaccine targeting expected 2026/2027 variants Syrian Arab News Agency 11:07
BioNTech Slides As Vaccine Sales Drop, Restructuring Plan Takes Shape Benzinga 17:21 Tue, 05 May Article paywall
BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback FiercePharma 16:46 Tue, 05 May
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update BioNTech (Press Release) 11:49 Tue, 05 May
BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 BioNTech (Press Release) 11:50 Tue, 21 Apr
BioNTech and DualityBio report positive data for trastuzumab pamirtecan Hospital Management 11:30 Mon, 13 Apr
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer BioNTech (Press Release) 12:10 Sat, 11 Apr